Home

Norris Medicines Ltd Quarterly Result

Image

Norris Medicines Ltd

NSE: NORRISMEDICINES

Net Profit - Last Quarter

₹ -0.28 Cr.

Last updated on: Feb 22, 2025

Norris Medicines Ltd Quarterly Results Key Highlights

  • The revenue of Norris Medicines Ltd for the Dec '24 is ₹ 1.11 crore as compare to the Sep '24 revenue of ₹ 1.27 crore.
  • This represent the decline of -12.6%a1# The ebitda of Norris Medicines Ltd for the Dec '24 is ₹ -0.02 crore as compare to the Sep '24 ebitda of ₹ -0.14 crore.
  • This represent the decline of -85.71%a1# The net profit of Norris Medicines Ltd for the Dec '24 is ₹ -0.28 crore as compare to the Sep '24 net profit of ₹ -0.36 crore.
  • This represent the decline of -22.22%a1#.

Norris Medicines Ltd Quarterly Results Analysis

Market Price of Norris Medicines Ltd

1M

1Y

3Y

5Y

Monitoring Norris Medicines Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 202520.48
20 Feb 202520.48
19 Feb 202520.58
18 Feb 202521
17 Feb 202521
14 Feb 202521
13 Feb 202521.4
12 Feb 202521.56
11 Feb 202521.76
10 Feb 202521.76

Historical Revenue of Norris Medicines Ltd

No data available

* All values are in crore

Historical EBITDA of Norris Medicines Ltd

No data available

* All values are in crore

Historical Net Profit of Norris Medicines Ltd

No data available

* All values are in crore

Norris Medicines Ltd News Hub

Norris Medicines reports standalone net loss of Rs 0.37 crore in the June 2024 quarter

Net Loss of Norris Medicines reported to Rs 0.37 crore in the quarter ended June 2024 as against net

Read more

16 Aug 24

Norris Medicines to discuss results

Norris Medicines will hold a meeting of the Board of Directors of the Company on 14 August 2024. Pow

Read more

09 Aug 24

Norris Medicines to conduct AGM

Norris Medicines announced that the 33th Annual General Meeting (AGM) of the company will be held on

Read more

16 Sept 24

Norris Medicines to table results

Norris Medicines will hold a meeting of the Board of Directors of the Company on 14 November 2024 Po

Read more

12 Nov 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Quarterly Results of Norris Medicines Ltd

What key financial metrics are included in Norris Medicines Ltd's quarterly results?

Key financial metrics in Norris Medicines Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Norris Medicines Ltd announce its quarterly results?

Norris Medicines Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Norris Medicines Ltd's quarterly performance impact its stock price?

Norris Medicines Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Norris Medicines Ltd's quarterly results on dividends?

The impact of Norris Medicines Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Norris Medicines Ltd's quarterly results?

Yes, Norris Medicines Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions